Year: 2016
Type: article
Abstract: INTRODUCTION: Tau-positron emission tomography (PET) imaging with AV1451 is sensitive to Alzheimer disease (AD)-related tau deposition in the brain. We (1) examined regional variation of average tau-PET standardized uptake value ratios (SUVRs) in a young normal population (30-49 years) and corrected for the regional variability and (2) tested if the standardized values (z-scores) scaled appropriately to capture regional Alzheimer-specific (i.e., amyloid sensitive) tau-PET changes in individuals aged 50+ years. METHODS: We identified 490 individuals (70 between 30-49 years as a reference group and 420 cognitively normal between 50-95 years of age) with tau-PET and amyloid PET scans from the Mayo Clinic Study of Aging. RESULTS: There was intrinsic regional variability in average tau-PET SUVR with uptakes higher in some regions than others, even in the younger individuals who would have minimal or no neurofibrillary tangles. We corrected for this using region of interest-specific z-scores based on the reference group. Amyloid and tau-PET uptake were associated throughout the brain after adjusting for age, with the highest correlations in the medial temporal regions. DISCUSSION: Regions with high-average SUVR are not necessarily those with the greatest tau pathology. Standardization is therefore recommended. Standardization of the data "realigns" the data such that the regional tau z-scores are informative of the disease process, that is, regions with high z-scores now coincide with regions correlated with amyloid deposition. Medial temporal structures, specifically entorhinal cortex-tau, may be useful as an AD-specific tau-PET signature due to its sensitivity to amyloid.
Institution: Mayo Clinic
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,540
Funders: Mayo Clinic, Mayo Foundation for Medical Education and Research, Elsie and Marvin Dekelboum Family Foundation, National Institutes of Health, Avid Radiopharmaceuticals, National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Center for Research Resources
Awards: Multimorbidity and Aging: Rochester Epidemiology Project, G3739245758, Alzheimers Disease Patient Registry, G3930010334, G4011678444, Evaluating and Extending Our Hypothetical Model of Alzheimer's Biomarkers, G5884129571, G6870540333, Development, Validation, and Application of an Imaging based CVD Scale, EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM, Brain Aging and Alzheimer's Biomarker Classification Using Amyloid PET, tau PET, and Neurodegeneration on MRI: Developing the ATN system, HOW DOES RESERVE MODIFY LINKS BETWEEN COGNITION & IMAGING INDICES OF AD PATHOLOGY, G9000038603, G9000148343, Mayo Alzheimer's Disease Research Center
OpenAlex ID: W2563261399
